Crosstalk between ferroptosis and sarmoptosis
Crosstalk between ferroptosis and sarmoptosis
批准号:
461705066
负责人:
Professor Dr. Axel Methner
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ferroptosis causes a specific form of iron-dependent programmed cell death characterized by glutathione depletion, inhibition of glutathione peroxidase 4 and lipid peroxidation that is finally executed by a fatal dysregulation of Ca2+ homeostasis. In the initial phase of ferroptosis, the cells upregulate NAD+-consuming pathways like Sirtuin 3, a mitochondrial deacetylase that uses NAD+ as substrate, to directly counteract production of reactive oxygen species and generate NADPH used to fuel glutathione reductase to recover glutathione and keeping glutathione peroxidase 4 active. This process consumes NAD+. Interestingly, another pathway of programmed cell death distinct form ferroptosis is triggered by NAD+ depletion. This pathway is active in degenerating axons severed from their cell bodies and is coined sarmoptosis because it involves dimerization of the protein SARM1. Sarmoptosis is characterized primarily by NAD+ depletion and accumulation of its precursor nicotinamide mononucleotide (NMN), but similar to ferroptosis also by activation of JNK kinases and a dysregulated Ca2+ homeostasis. Based on the obvious overlapping features of these cell death programs, we claim that a crosstalk between ferroptosis and sarmoptosis exists. We hypothesize that the combination of increased NAD+ consumption and inhibition of NMN-generating enzymes by JNK kinases during ferroptosis results in a disbalance of NMN/NAD+ that triggers sarmoptosis and activates the fatal Ca2+ dysregulation that precedes demise. On the other hand, we propose that sarmoptosis triggers a dysfunction of Sirtuin 3 activity caused by lack of its substrate NAD+ which probably results in a GSSG/GSH disbalance during the execution of sarmoptosis and subsequent features of ferroptosis. To obtain more insight into these pathways, we therefore propose studies to study hallmarks of sarmoptosis in ferroptosis and resistance against ferroptosis, to clarify whether inhibiting sarmoptosis protects against ferroptosis and to elucidate the relevance of ferroptosis for the execution of axonal degeneration. This work is of high relevance as it aims to elucidate fundamental aspects of cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TMBIM5 is a Ca2+ channel in the inner mitochondrial membrane
-
批准号:406941494
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Axel Methner
-
依托单位:
Thiol switches controlled by the glutathione-S-transferase GDAP1
-
批准号:386417025
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Axel Methner
-
依托单位:
Sensor, channel, pump and leak - TMBIM6 assembles a multi-protein complex that governs the Ca2+ content of the endoplasmic reticulum
-
批准号:333214844
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Axel Methner
-
依托单位:
The role of NECAB2 in brain physiology and in Huntington s disease
-
批准号:281465568
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Axel Methner
-
依托单位:
Mechanismen der Bl-1/Bcl-2-vermittelten Reduktion des ER-Kalziumgehalts und der damit verbundenen antipoptotischen Wirkung
-
批准号:32295278
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Axel Methner
-
依托单位:
Charcot Marie Tooth disease 4A - GDAP1-mediated redox-dependent interaction of mitochondria with the cytoskeleton
-
批准号:517361457
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Axel Methner
-
依托单位:
The role of the Fe/S cluster protein CISD1 in Parkinson’s disease
-
批准号:445683311
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Axel Methner
-
依托单位:
海外基金